Centre intégré de santé et de services sociaux de Chaudière-Appalaches

Institution (Healthcare)

Also Known As

CISSCA Chaudière-Appalaches, CISSS Chaudière-Appalaches, CISSS of Chaudière-Appalaches, Centre de Recherche du Centre intégré de santé et de services sociaux de Chaudière-Appalaches, Centre intégré de santé et de services sociaux de Chaudière-Appalaches, Centres intégrés de santé et de services sociaux de Chaudière-Appalaches (CISSS), Centres intégrés universitaires de santé et de services sociaux de Chaudière-Appalaches (CIUSSS) · Acronym: CSSS

Publications

26.5K

Citations

Authors

287

Concepts

About

Centre intégré de santé et de services sociaux de Chaudière-Appalaches is a healthcare institution in Saint Romuald, Canada known for medicine, public health, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	12	13	496
2	Engineering	4	4	123
3	Education	3	6	141
4	Arts	2	2	44
5	Management	1	1	25

Centre intégré de santé et de services sociaux de Chaudière-Appalaches

Publications

26.5K

Citations

Page 1

	Year	Citations
Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis J William L Brown, Alasdair Coles, Dana Horáková, JAMA	2019	511
Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study Anna He, B. Merkel, J William L Brown, The Lancet Neurology Disease ProgressionNeurological DisorderClinical EpidemiologyClinical TrialsOutcomes Research	2020	401
Canadian Stroke Best Practice Recommendations: Rehabilitation, Recovery, and Community Participation following Stroke. <i>Part One: Rehabilitation and Recovery Following Stroke;</i> 6th Edition Update 2019 Robert Teasell, Nancy M. Salbach, Norine Foley, International Journal of Stroke	2020	397
Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial Michelle Sholzberg, Grace H. Tang, Hassan Rahhal, BMJ	2021	368
Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults Alexander A. C. Leung, Stella S. Daskalopoulou, Kaberi Dasgupta, Canadian Journal of Cardiology Risk AssessmentBlood Pressure MonitoringHypertensionPreventive MedicineCardiovascular Disease	2017	319
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial Philippe Bégin, Jeannie Callum, Erin Jamula, Nature Medicine	2021	268
Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non–Small-Cell Lung Cancer: CheckMate 153 David Waterhouse, Edward B. Garon, Jason C. Chandler, Journal of Clinical Oncology	2020	223
Safety, Efficacy, and Patient-Reported Health-Related Quality of Life and Symptom Burden with Nivolumab in Patients with Advanced Non–Small Cell Lung Cancer, Including Patients Aged 70 Years or Older or with Poor Performance Status (CheckMate 153) David R. Spigel, Michael McCleod, Robert M. Jotte, Journal of Thoracic Oncology Checkmate 153OncologyCancer ManagementOutcomes ResearchPatient-reported Outcome	2019	184
Integrating Social Theory Into Public Health Practice Louise Potvin, Sylvie Gendron, Angèle Bilodeau, American Journal of Public Health	2005	168
Combined impairments in vision, hearing and cognition are associated with greater levels of functional and communication difficulties than cognitive impairment alone: Analysis of interRAI data for home care and long-term care recipients in Ontario Dawn M. Guthrie, Jacob G. S. Davidson, Nicole Williams, PLoS ONE	2018	166

Page 1